These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3002244)

  • 1. Semiautomated assessment of in vitro activity of potential antileishmanial drugs.
    Berman JD; Gallalee JV
    Antimicrob Agents Chemother; 1985 Dec; 28(6):723-6. PubMed ID: 3002244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-structural alterations in Leishmania tropica within human macrophages exposed to antileishmanial drugs in vitro.
    Langreth SG; Berman JD; Riordan GP; Lee LS
    J Protozool; 1983 Aug; 30(3):555-61. PubMed ID: 6315928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.
    Berman JD; Lee LS
    J Parasitol; 1984 Apr; 70(2):220-5. PubMed ID: 6088749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation.
    Berman JD
    J Parasitol; 1984 Aug; 70(4):561-2. PubMed ID: 6502359
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
    Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
    Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of purine analogs against Leishmania tropica within human macrophages in vitro.
    Berman JD; Lee LS; Robins RK; Revankar GR
    Antimicrob Agents Chemother; 1983 Aug; 24(2):233-6. PubMed ID: 6638989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism.
    Looker DL; Martinez S; Horton JM; Marr JJ
    J Infect Dis; 1986 Aug; 154(2):323-7. PubMed ID: 3014012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of oral drugs against Leishmania tropica in human macrophages in vitro.
    Berman JD; Lee LS
    Am J Trop Med Hyg; 1983 Sep; 32(5):947-51. PubMed ID: 6312823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
    Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M
    Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
    Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N
    Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
    Gebre-Hiwot A; Tadesse G; Croft SL; Frommel D
    Acta Trop; 1992 Aug; 51(3-4):237-45. PubMed ID: 1359751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial activity of sodium stibogluconate fractions.
    Roberts WL; Rainey PM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1842-6. PubMed ID: 8239593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agents.
    Chauhan SS; Gupta L; Mittal M; Vishwakarma P; Gupta S; Chauhan PM
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6191-4. PubMed ID: 20850302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.
    Neal RA; Croft SL
    J Antimicrob Chemother; 1984 Nov; 14(5):463-75. PubMed ID: 6096347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.
    Berman JD; Wyler DJ
    J Infect Dis; 1980 Jul; 142(1):83-6. PubMed ID: 6249874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of leishmanial protein kinase by antileishmanial drugs.
    Berman JD
    Am J Trop Med Hyg; 1988 Mar; 38(2):298-303. PubMed ID: 2833126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.
    Delgado G; Puentes F; Moreno A; Patarroyo ME
    Pharmacol Res; 2001 Oct; 44(4):281-6. PubMed ID: 11592861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes.
    Muniaraj M; Sinha PK; Das P
    Trop Biomed; 2010 Dec; 27(3):657-61. PubMed ID: 21399608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
    Ephros M; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.